Article info
Research
Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic pain
- Correspondence to Professor David C Currow, Palliative and Supportive Services, Health Sciences Building, Repatriation General Hospital, Daws Road, Daw Park, Adelaide, SA 5041, Australia; david.currow{at}health.sa.gov.au
Citation
Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic pain
Publication history
- Received April 10, 2014
- Revision received July 31, 2014
- Accepted September 9, 2014
- First published October 16, 2014.
Online issue publication
April 19, 2016
Article Versions
- Previous version (19 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/